TY - JOUR
T1 - Opposing roles of dendritic cell subsets in experimental GN
AU - Brähler, Sebastian
AU - Zinselmeyer, Bernd H.
AU - Raju, Saravanan
AU - Nitschke, Maximilian
AU - Suleiman, Hani
AU - Saunders, Brian T.
AU - Johnson, Michael W.
AU - Böhner, Alexander M.C.
AU - Viehmann, Susanne F.
AU - Theisen, Derek J.
AU - Kretzer, Nicole M.
AU - Briseño, Carlos G.
AU - Zaitsev, Konstantin
AU - Ornatsky, Olga
AU - Chang, Qing
AU - Carrero, Javier A.
AU - Kopp, Jeffrey B.
AU - Artyomov, Maxim N.
AU - Kurts, Christian
AU - Murphy, Kenneth M.
AU - Miner, Jeffrey H.
AU - Shaw, Andrey S.
N1 - Funding Information:
M.N. and A.S.S are employees of Genentech (South San Francisco, CA). O.O. and Q.C. are employees of Fluidigm Inc. (Markham, ON, Canada). J.H.M. has received grants from Hoffmann-La Roche (Basel, Switzerland) and RGDI3, Inc. (Boston, MA); has provided consultation to Third Rock Ventures (Boston, MA); and has received licensing fees from Eli Lilly (Indianapolis, IN) and Genentech (South San Francisco, CA).
Funding Information:
This study was funded by scholarship DFG BR4917/1-1 from the Deutsche Forschungsgemeinschaft and the Köln Fortune Program of the University of Cologne (to S.B.) and National Institutes of Health (NIH) grant R01DK058366 (to J.H.M. and A.S.S.). H.S. was supported by a Career Development Fellowship from the Nephrotic Syndrome Study Network Consortium (funded by NIH grant U54DK083912) and Scientist Development grant 17SDG33420069 from the American Heart Association. K.Z. was supported by Government of Russian Federation grant 074-U01. J.B.K. was supported by the Intramural Research Program, the National Institute of Diabetes and Digestive and Kidney Diseases, the NIH. The Genome Technology Access Center is partially supported by National Cancer Center Support grant P30CA91842 (to the Siteman Cancer Center); Institute for Clinical and Translational Sciences/Clinical and Translational Science Award grant UL1TR000448 from the National Center for Research Resources (NCRR), a component of the NIH; and the NIH Roadmap for Medical Research.
Funding Information:
We thank C. Stander, L. LaFata, and J. Richardson for excellent technical support. We also thank the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for help with genomic analysis. This study was funded by scholarship DFG BR4917/1-1 from the Deutsche Forschungsgemeinschaft and the Köln Fortune Program of the University of Cologne (to S.B.) and National Institutes of Health (NIH) grant R01DK058366 (to J.H.M. and A.S.S.). H.S. was supported by a Career Development Fellowship from the Nephrotic Syndrome Study Network Consortium (funded by NIH grant U54DK083912) and Scientist Development grant 17SDG33420069 from the American Heart Association. K.Z. was supported by Government of Russian Federation grant 074-U01. J.B.K. was supported by the Intramural Research Program, the National Institute of Diabetes and Digestive and Kidney Diseases, the NIH. The Genome Technology Access Center is partially supported by National Cancer Center Support grant P30CA91842 (to the Siteman Cancer Center); Institute for Clinical and Translational Sciences/Clinical and Translational Science Award grant UL1TR000448 from the National Center for Research Resources (NCRR), a component of the NIH; and the NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of the NCRR or the NIH.
Publisher Copyright:
Copyright © 2018 by the American Society of Nephrology.
PY - 2018/1
Y1 - 2018/1
N2 - Dendritic cells (DCs) are thought to form a dendritic network across barrier surfaces and throughout organs, including the kidney, to perform an important sentinel function. However, previous studies of DC function used markers, such as CD11c or CX3CR1, that are not unique to DCs. Here, we evaluated the role of DCs in renal inflammation using a CD11c reporter mouse line and two mouse lines with DC-specific reporters, Zbtb46-GFP and Snx22-GFP. Multiphoton microscopy of kidney sections confirmed that most of the dendritically shaped CD11c+ cells forming a network throughout the renal interstitium expressed macrophage-specific markers. In contrast, DCs marked by Zbtb46-GFP or Snx22-GFP were less abundant, concentrated around blood vessels, and round in shape. We confirmed this pattern of localization using imaging mass cytometry. Motility measurements showed that resident macrophages were sessile, whereas DCs were motile before and after inflammation. Although uninflamed glomeruli rarely contained DCs, injury with nephrotoxic antibodies resulted in accumulation of ZBTB46+ cells in the periglomerular region. ZBTB46 identifies all classic DCs, which can be categorized into two functional subsets that express either CD103 or CD11b. Depletion of ZBTB46+ cells attenuated the antibody-induced kidney injury, whereas deficiency of the CD103+ subset accelerated injury through a mechanism that involved increased neutrophil infiltration. RNA sequencing 7 days after nephrotoxic antibody injection showed that CD11b+ DCs expressed the neutrophil-attracting cytokine CXCL2, whereas CD103+ DCs expressed high levels of several anti-inflammatory genes. These results provide new insights into the distinct functions of the two major DC subsets in glomerular inflammation.
AB - Dendritic cells (DCs) are thought to form a dendritic network across barrier surfaces and throughout organs, including the kidney, to perform an important sentinel function. However, previous studies of DC function used markers, such as CD11c or CX3CR1, that are not unique to DCs. Here, we evaluated the role of DCs in renal inflammation using a CD11c reporter mouse line and two mouse lines with DC-specific reporters, Zbtb46-GFP and Snx22-GFP. Multiphoton microscopy of kidney sections confirmed that most of the dendritically shaped CD11c+ cells forming a network throughout the renal interstitium expressed macrophage-specific markers. In contrast, DCs marked by Zbtb46-GFP or Snx22-GFP were less abundant, concentrated around blood vessels, and round in shape. We confirmed this pattern of localization using imaging mass cytometry. Motility measurements showed that resident macrophages were sessile, whereas DCs were motile before and after inflammation. Although uninflamed glomeruli rarely contained DCs, injury with nephrotoxic antibodies resulted in accumulation of ZBTB46+ cells in the periglomerular region. ZBTB46 identifies all classic DCs, which can be categorized into two functional subsets that express either CD103 or CD11b. Depletion of ZBTB46+ cells attenuated the antibody-induced kidney injury, whereas deficiency of the CD103+ subset accelerated injury through a mechanism that involved increased neutrophil infiltration. RNA sequencing 7 days after nephrotoxic antibody injection showed that CD11b+ DCs expressed the neutrophil-attracting cytokine CXCL2, whereas CD103+ DCs expressed high levels of several anti-inflammatory genes. These results provide new insights into the distinct functions of the two major DC subsets in glomerular inflammation.
UR - http://www.scopus.com/inward/record.url?scp=85040107842&partnerID=8YFLogxK
U2 - 10.1681/ASN.2017030270
DO - 10.1681/ASN.2017030270
M3 - Article
C2 - 29217759
AN - SCOPUS:85040107842
SN - 1046-6673
VL - 29
SP - 138
EP - 154
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 1
ER -